What is needed from the EMA to be better prepared for future health threats?

The COVID-19 pandemic has shown the need to improve EU health threat preparedness. Listen to our podcast with Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut, where we explore what is needed from the European Medicines Agency (EMA) to address future challenges.